EE05230B1 - Suukaudselt manustatav galantamiinilahus ja meetod selle valmistamiseks - Google Patents

Suukaudselt manustatav galantamiinilahus ja meetod selle valmistamiseks

Info

Publication number: EE05230B1
Authority: EE; Estonia
Prior art keywords: preparation; solution; galantamine; oral; oral galantamine
Prior art date: 1999-10-26

Application number

EEP200200213A

Other languages

English (en)

Inventor

Karel Jozef Fran�ois Marc

Mathilde Jozef Kempen Tony

Andr� Jos�e De Proost Eddy

Original Assignee

Janssen Pharmaceutica N.V.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-10-26

Filing date

2000-10-16

Publication date

2009-12-15

2000-10-16 Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.

2003-06-16 Publication of EE200200213A publication Critical patent/EE200200213A/et

2009-12-15 Publication of EE05230B1 publication Critical patent/EE05230B1/et

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Neurology (AREA)
General Chemical & Material Sciences (AREA)
Biomedical Technology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Neurosurgery (AREA)
Epidemiology (AREA)
Psychiatry (AREA)
Physical Education & Sports Medicine (AREA)
Addiction (AREA)
Orthopedic Medicine & Surgery (AREA)
Hospice & Palliative Care (AREA)
Immunology (AREA)
Rheumatology (AREA)
Psychology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Saccharide Compounds (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)

EEP200200213A 1999-10-26 2000-10-16 Suukaudselt manustatav galantamiinilahus ja meetod selle valmistamiseks EE05230B1 (et)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP99203512		1999-10-26
PCT/EP2000/010203 WO2001030318A1 (en)	1999-10-26	2000-10-16	Oral solution containing galanthamine and a sweetening agent

Publications (2)

Publication Number	Publication Date
EE200200213A EE200200213A (et)	2003-06-16
EE05230B1 true EE05230B1 (et)	2009-12-15

Family

ID=8240778

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP200200213A EE05230B1 (et)	1999-10-26	2000-10-16	Suukaudselt manustatav galantamiinilahus ja meetod selle valmistamiseks

Country Status (29)

Country	Link
EP (1)	EP1237539B1 (et)
JP (1)	JP2003512415A (et)
KR (1)	KR100502391B1 (et)
CN (1)	CN1200691C (et)
AR (1)	AR026243A1 (et)
AT (1)	ATE306904T1 (et)
AU (1)	AU780826C (et)
BG (1)	BG65792B1 (et)
BR (1)	BR0015025A (et)
CA (1)	CA2388830C (et)
CZ (1)	CZ301996B6 (et)
DE (1)	DE60023341T2 (et)
DK (1)	DK1237539T3 (et)
EA (1)	EA005683B1 (et)
EE (1)	EE05230B1 (et)
ES (1)	ES2250211T3 (et)
HR (1)	HRP20020332B1 (et)
HU (1)	HUP0203484A3 (et)
IL (2)	IL149310A0 (et)
IS (1)	IS2628B (et)
MX (1)	MXPA02004149A (et)
NO (1)	NO332096B1 (et)
PL (1)	PL201694B1 (et)
SI (1)	SI1237539T1 (et)
SK (1)	SK285643B6 (et)
TW (1)	TW592725B (et)
UA (1)	UA76095C2 (et)
WO (1)	WO2001030318A1 (et)
ZA (1)	ZA200203313B (et)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20030162770A1 (en) *	2002-02-22	2003-08-28	Davis Bonnie M.	Use of modulators of nicotinic receptors for treatment of cognitive dysfunction
WO2005016327A2 (en) *	2003-08-13	2005-02-24	Janssen Pharmaceutica, N.V.	Treatment of sleep disorders with cholinesterase inhibitors
EP1763337A2 (en) *	2003-12-31	2007-03-21	Actavis Group HF	Immediate, controlled and sustained release formulations of galanthamine
US8709521B2 (en) *	2007-05-22	2014-04-29	The Coca-Cola Company	Sweetener compositions having enhanced sweetness and improved temporal and/or flavor profiles
LT2667715T (lt) *	2011-01-27	2017-11-10	Neuren Pharmaceuticals Limited	Autizmo spektro susirgimų gydymas, naudojant glicil-l-2-metilprolil-l-glutamo rūgštį
WO2014059363A1 (en) *	2012-10-11	2014-04-17	Antrim Pharmaceuticals Llc	Oral solution formulations of aripiprazole
JP6457582B2 (ja) *	2017-04-14	2019-01-23	エルメッドエーザイ株式会社	ガランタミン含有医薬組成物、並びに医薬組成物におけるガランタミンの苦味抑制方法、及びガランタミンの苦味抑制剤
CN117717558A (zh) *	2023-12-06	2024-03-19	艾威药业(珠海)有限公司	加兰他敏及其药学上可接受的盐在制备治疗眼部疾病的药物中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4010079A1 (de) *	1990-03-29	1991-10-02	Lohmann Therapie Syst Lts	Pharmazeutische formulierung zur behandlung des alkoholismus
US5272137A (en) *	1992-02-14	1993-12-21	Mcneil-Pfc, Inc.	Aqueous pharmaceutical suspension for pharmaceutical actives
US6323195B1 (en) *	1993-10-15	2001-11-27	Aventis Pharmaceuticals Inc.	Galanthamine derivatives as acetylcholinesterase inhibitors
JPH10273435A (ja) *	1997-01-29	1998-10-13	Fujisawa Pharmaceut Co Ltd	内服用液剤

2000
- 2000-10-16 CA CA002388830A patent/CA2388830C/en not_active Expired - Lifetime
- 2000-10-16 HU HU0203484A patent/HUP0203484A3/hu unknown
- 2000-10-16 HR HR20020332A patent/HRP20020332B1/xx not_active IP Right Cessation
- 2000-10-16 UA UA2002054064A patent/UA76095C2/uk unknown
- 2000-10-16 WO PCT/EP2000/010203 patent/WO2001030318A1/en not_active Ceased
- 2000-10-16 BR BR0015025-8A patent/BR0015025A/pt not_active Application Discontinuation
- 2000-10-16 ES ES00975872T patent/ES2250211T3/es not_active Expired - Lifetime
- 2000-10-16 SK SK530-2002A patent/SK285643B6/sk not_active IP Right Cessation
- 2000-10-16 EP EP00975872A patent/EP1237539B1/en not_active Expired - Lifetime
- 2000-10-16 AT AT00975872T patent/ATE306904T1/de active
- 2000-10-16 DK DK00975872T patent/DK1237539T3/da active
- 2000-10-16 SI SI200030782T patent/SI1237539T1/sl unknown
- 2000-10-16 JP JP2001532738A patent/JP2003512415A/ja active Pending
- 2000-10-16 PL PL362849A patent/PL201694B1/pl unknown
- 2000-10-16 CZ CZ20021329A patent/CZ301996B6/cs not_active IP Right Cessation
- 2000-10-16 AU AU13849/01A patent/AU780826C/en not_active Expired
- 2000-10-16 EA EA200200486A patent/EA005683B1/ru not_active IP Right Cessation
- 2000-10-16 IL IL14931000A patent/IL149310A0/xx active IP Right Grant
- 2000-10-16 CN CNB008147388A patent/CN1200691C/zh not_active Expired - Lifetime
- 2000-10-16 DE DE60023341T patent/DE60023341T2/de not_active Expired - Lifetime
- 2000-10-16 EE EEP200200213A patent/EE05230B1/et unknown
- 2000-10-16 KR KR10-2002-7003258A patent/KR100502391B1/ko not_active Expired - Lifetime
- 2000-10-16 TW TW089121526A patent/TW592725B/zh not_active IP Right Cessation
- 2000-10-16 MX MXPA02004149A patent/MXPA02004149A/es active IP Right Grant
- 2000-10-25 AR ARP000105621A patent/AR026243A1/es not_active Application Discontinuation
2002
- 2002-02-28 IS IS6291A patent/IS2628B/is unknown
- 2002-03-20 BG BG106534A patent/BG65792B1/bg unknown
- 2002-04-24 IL IL149310A patent/IL149310A/en unknown
- 2002-04-25 ZA ZA200203313A patent/ZA200203313B/xx unknown
- 2002-04-26 NO NO20022003A patent/NO332096B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
KR100502391B1 (ko)	2005-07-19
NO20022003D0 (no)	2002-04-26
HUP0203484A2 (hu)	2003-02-28
SK285643B6 (sk)	2007-05-03
DE60023341T2 (de)	2006-07-27
JP2003512415A (ja)	2003-04-02
IL149310A0 (en)	2002-11-10
HK1049619A1 (en)	2003-05-23
SK5302002A3 (en)	2002-10-08
WO2001030318A1 (en)	2001-05-03
EP1237539B1 (en)	2005-10-19
HRP20020332B1 (hr)	2011-02-28
SI1237539T1 (sl)	2006-04-30
PL362849A1 (en)	2004-11-02
ZA200203313B (en)	2003-11-26
AU780826B2 (en)	2005-04-21
CZ20021329A3 (cs)	2002-08-14
AU1384901A (en)	2001-05-08
NO332096B1 (no)	2012-06-18
AU780826C (en)	2006-02-16
NO20022003L (no)	2002-06-18
BG106534A (en)	2002-12-29
CA2388830C (en)	2006-09-19
ATE306904T1 (de)	2005-11-15
MXPA02004149A (es)	2002-10-17
CA2388830A1 (en)	2001-05-03
HRP20020332A2 (en)	2004-02-29
DK1237539T3 (da)	2006-02-27
ES2250211T3 (es)	2006-04-16
CZ301996B6 (cs)	2010-09-01
DE60023341D1 (de)	2006-03-02
IS2628B (is)	2010-05-15
PL201694B1 (pl)	2009-04-30
BR0015025A (pt)	2002-06-18
UA76095C2 (en)	2006-07-17
EP1237539A1 (en)	2002-09-11
EA200200486A1 (ru)	2002-10-31
BG65792B1 (bg)	2009-12-31
IS6291A (is)	2002-02-28
AR026243A1 (es)	2003-02-05
IL149310A (en)	2006-12-10
HUP0203484A3 (en)	2004-12-28
CN1200691C (zh)	2005-05-11
EA005683B1 (ru)	2005-04-28
KR20020026010A (ko)	2002-04-04
CN1382037A (zh)	2002-11-27
TW592725B (en)	2004-06-21
EE200200213A (et)	2003-06-16

Publication	Publication Date	Title
FI19992360L (fi)	2001-05-02	Tuote ja menetelmä sen valmistamiseksi
EE05021B1 (et)	2008-06-16	Enterokattega ravimkoostis ja selle valmistamise meetod
EE04926B1 (et)	2007-12-17	Enterokattega ravimkoostis ja selle valmistamise meetod
DE60027076D1 (de)	2006-05-18	Dental-Verbundwerkstoff
FI991485A0 (fi)	1999-06-30	Uusi farmaseuttinen koostumus
PT1150966E (pt)	2003-01-31	Metodo de preparacao de 5-cianoftalido
EE05214B1 (et)	2009-10-15	Polool-IFN- β konjugaat, selle valmistamismeetod ja farmatseutiline kompositsioon
EE04464B1 (et)	2005-04-15	Indalüülasendatud benseenkarboksamiidid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid
DK1140109T3 (da)	2006-05-15	Trefaset oralt antikonceptionsmiddel
DK1128831T3 (da)	2005-01-17	Farmaceutisk moxifloxacinpræparat
EE04721B1 (et)	2006-10-16	Fenüülksantiini derivaadid, nende valmistamismeetodid ja kasutamine
EE200200150A (et)	2003-04-15	Preparaat
DK1466615T3 (da)	2009-08-31	Farmaceutisk præparat
EE200200105A (et)	2003-04-15	Radiofarmatseutilised saadused ja nende valmistamise meetod
FI19992070L (fi)	2001-03-28	Uudet fukosyloidut oligosakkaridit ja menetelmä niiden valmistamiseksi
DE60007530D1 (de)	2004-02-05	Oral wirksame androgene
EE04490B1 (et)	2005-06-15	Ühend, selle valmistamise meetod ning kasutamine meditsiinis
EE04717B1 (et)	2006-10-16	Indolüülpiperidiinühendid, nende valmistamismeetod, kompositsioon ja nende kasutamine
DE60043058D1 (de)	2009-11-12	Dentalwerkstoffe
EE200100314A (et)	2002-08-15	Meetod farmatseutilise kompositsiooni valmistamiseks, farmatseutiline kompositsioon ja selle kasutamine
EE04902B1 (et)	2007-10-15	Mikrograanul, selle valmistamismeetod ja farmatseutiline preparaat
EE05230B1 (et)	2009-12-15	Suukaudselt manustatav galantamiinilahus ja meetod selle valmistamiseks
EE03387B1 (et)	2001-04-16	Kombineeritud ravimpreparaat, selle kasutamine ja meetod selle valmistamiseks
DK1176982T3 (da)	2004-03-29	Prucaloprid oral opløsning
FI982412L (fi)	2000-05-07	Rehu ja menetelmä sen valmistamiseksi

Legal Events

Date	Code	Title	Description
2011-02-15	KB4A	Valid patent at the end of a year	Effective date: 20101231